Full Text
The Impact of Scottish Medicines Consortium (SMC) Process Changes on Acceptance Rates for New Medicines for End of Life and Very Rare Conditions

Abstract

Authors

M McMurray N Downes A Brown A Lee A Macdonald B O'Toole

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×